Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line

Detalles Bibliográficos
Autores principales: Lafarge, S, Ferrara, M, Bignon, YJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300822/
http://dx.doi.org/10.1186/bcr123
_version_ 1782226366839652352
author Lafarge, S
Ferrara, M
Bignon, YJ
author_facet Lafarge, S
Ferrara, M
Bignon, YJ
author_sort Lafarge, S
collection PubMed
description
format Online
Article
Text
id pubmed-3300822
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33008222012-03-14 Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line Lafarge, S Ferrara, M Bignon, YJ Breast Cancer Res Meeting Abstract BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300822/ http://dx.doi.org/10.1186/bcr123 Text en Copyright ©2000 Current Science Ltd
spellingShingle Meeting Abstract
Lafarge, S
Ferrara, M
Bignon, YJ
Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title_full Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title_fullStr Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title_full_unstemmed Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title_short Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
title_sort ribozymes targeting the tumor suppressor brca1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in hbl100 breast cancer cell line
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300822/
http://dx.doi.org/10.1186/bcr123
work_keys_str_mv AT lafarges ribozymestargetingthetumorsuppressorbrca1leadtoincreasedchemosensitivitytocisplatinandetoposideandchemoresistancetomicrotubuleinterferingagentsinhbl100breastcancercellline
AT ferraram ribozymestargetingthetumorsuppressorbrca1leadtoincreasedchemosensitivitytocisplatinandetoposideandchemoresistancetomicrotubuleinterferingagentsinhbl100breastcancercellline
AT bignonyj ribozymestargetingthetumorsuppressorbrca1leadtoincreasedchemosensitivitytocisplatinandetoposideandchemoresistancetomicrotubuleinterferingagentsinhbl100breastcancercellline

Ejemplares similares